查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1358130

DNA/基因微陣列市場：按類型、按用途、按最終用戶、按地區

DNA/Gene Microarray Market, By Type,By Application,By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2023 年，全球 DNA/基因微陣列市場將達到 42.4 億美元，預測期內（2023-2030 年）年複合成長率為 12.9%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 42.4億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 12.90% 2030年市場規模預測 99.1億美元
2023 年按類型分類的 DNA/基因微陣列的全球市場佔有率(%)
DNA/基因微陣列市場-IMG1

DNA 晶片、生物晶片或 DNA 微陣列由玻璃、矽晶圓或尼龍膜等材料製成的顯微鏡玻片結構，其上印有數千個微觀斑點。已知的 DNA 序列和基因規律地排列在這些點上。 DNA微陣列利用核酸雜交的原理，DNA微陣列的類型包括cDNA微陣列、寡聚DNA微陣列、BAC微陣列和SNP微陣列。 DNA 晶片的用途包括轉錄組和蛋白質組研究、疾病診斷和微生物鑒定。 DNA 微陣列或晶片是一種半導體表面，其上附著有多種基因的序列和探針。 DNA 微陣列用於對基因組的不同區域進行基因分型並同時評估多個基因的表達量。此方法可應用於臨床診斷、農業和環境管理等領域。

市場動態

DNA/基因微陣列結合了生物資料和統計專業知識，為各種生物系統提供了新的觀點。 DNA/基因微陣列檢測樣本中基因 (mRNA) 轉錄物的水平，並可將數千個基因片段放置在陣列上，從而提供癌症中基因表現的全基因組視圖。因此，癌症患病的增加預計將在預測期內推動市場成長。例如，根據全球癌症罹患率和死亡率資料庫Globocan 發布的一份報告，2021 年 2 月，2020 年全球報告了 1,930 萬新癌症病例。女性乳癌已超過肺癌成為最常見的癌症，預計 2020 年全球整體新增病例將達 230 萬例，其次是肺癌、大腸癌、攝護腺癌和胃腸癌。

此外，根據美國美國癌症診斷人數為 1,603,844 人，癌症死亡人數為 602,347 人。

本研究的主要特點

  • 該研究報告對全球DNA/基因微陣列市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率(CAGR) 。它揭示了各個細分市場的潛在收入機會，並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球 DNA/基因微陣列市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型經營團隊、市場擴張和行銷策略做出資訊的決策。
  • 全球 DNA/基因微陣列市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 透過用於分析全球 DNA/基因微陣列市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

    • 市場動態
  • 促進因素
  • 抑制因素
  • 市場機會
    • 影響分析
    • 合併、收購和合作
    • 法規場景
    • 主要進展
    • PEST分析
    • 波特的分析
    • 技術進步
    • 製造商收入

第4章 全球DNA/基因微陣列市場，COVID-19 的影響分析

    • 經濟影響
    • 新型冠狀病毒（COVID-19）的流行病學
    • 對需求和供給的影響

第5章 全球DNA/基因微陣列市場，依類型，2018-2030 年

  • 寡核苷酸DNA微陣列
  • 互補DNA微陣列

第6章 全球DNA/基因微陣列市場，依用途，2018-2030

  • 基因組學
  • 蛋白質體學
  • 農業生物學
  • 環境
  • 醫藥研發
  • 癌症/腫瘤學
  • 其他（SNP分析等）

第7章 全球DNA/基因微陣列市場，依最終用戶分類，2018-2030 年

  • 生物製藥和製藥公司
  • 診斷實驗室
  • 研究機構
  • 其他（學術機構等）

第8章 全球DNA/基因微陣列市場（按地區），2018-2030 年

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

第10章 章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI3825

The global DNA/gene microarray market is estimated to be valued at US$ 4.24 Billion in 2023 and is expected to exhibit a CAGR of 12.9% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 4.24 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.90% 2030 Value Projection: US$ 9.91 Bn
Global DNA/Gene Microarray Market Share (%), By Type, 2023
DNA/Gene Microarray Market - IMG1

DNA chips, biochips, or DNA microarrays consist of a microscope slide made of materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an ordered sequence. DNA microarrays use the nucleic acid hybridization principle, and types of DNA microarrays include cDNA microarrays, oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include the study of transcriptomes and proteomes, the diagnosis of diseases, the identification of microbes, and others. A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields.

Market Dynamics

The field of cancer research has made the most extensive use of DNA/gene microarrays, which combine biological data with statistical expertise to provide fresh perspectives on a variety of biological systems. A DNA/gene microarray, therefore, measures the levels of gene (mRNA) transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to fuel market growth over the forecast period. For instance, in February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, according to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020.

Key features of the study:

  • This report provides an in-depth analysis of the global DNA/gene microarray market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global DNA/gene microarray market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Perkin Elmer, Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global DNA/gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA/gene microarray market.

Detailed Segmentation:

  • Global DNA/Gene Microarray Market, By Type:
    • Oligonucleotide DNA Microarrays
    • Complementary DNA Microarrays
  • Global DNA/Gene Microarray Market, By Application:
    • Genomics
    • Proteomics
    • Agricultural Biology
    • Environment
    • Drug Research and Development
    • Cancer/oncology
    • Others (SNP Analysis, etc.)
  • Global DNA/Gene Microarray Market, By End User:
    • Biopharmaceutical and Pharmaceutical Companies
    • Diagnostic Laboratories
    • Research Laboratories
    • Others (Academic Institutes, etc.)
  • Global DNA/Gene Microarray Market, By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER'S Analysis
    • Technological Advancements
    • Manufacturer Revenue

4. Global DNA/Gene Microarray Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global DNA/Gene Microarray Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oligonucleotide DNA Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Complementary DNA Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global DNA/Gene Microarray Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Agricultural Biology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Environment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Drug Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Cancer/Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others (SNP Analysis, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global DNA/Gene Microarray Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Biopharmaceutical and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others(Academic Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global DNA/Gene Microarray Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact